Effects of toremifene and letrozole on serum lipids and bone metabolism in post-menopausal patients with estrogen receptor-positive breast cancer

Trial Profile

Effects of toremifene and letrozole on serum lipids and bone metabolism in post-menopausal patients with estrogen receptor-positive breast cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Apr 2014

At a glance

  • Drugs Toremifene (Primary) ; Letrozole
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Apr 2014 New trial record
    • 21 Mar 2014 Results presented at the 9th European Breast Cancer Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top